ICUI — ICU Medical Inc

ICU Medical Inc (ICUI) is a medical instruments & supplies company listed on NASDAQ. It is led by Vivek Jain, based in 951 Calle Amanecer, San Clemente, CA, United States, 92673, with about 13,000 employees. ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Latest reported ICUI revenue for 2025-09-30 was $537.0M. Net income was -$3.4M. Revenue was down 2.2% from 2025-06-30 to 2025-09-30. ICUI currently screens at market cap $3.45B and trailing P/E 73.8.

Use this ICUI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ICUI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ICUI SEC filings page. Lician reads the product cache first so this HTML stays unique to ICU Medical Inc even when a live quote feed is slow.